• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺部板层小体的通道和转运体:在健康和疾病中的作用。

Channels and Transporters of the Pulmonary Lamellar Body in Health and Disease.

机构信息

Institute of General Physiology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany.

出版信息

Cells. 2021 Dec 24;11(1):45. doi: 10.3390/cells11010045.

DOI:10.3390/cells11010045
PMID:35011607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8750383/
Abstract

The lamellar body (LB) of the alveolar type II (ATII) cell is a lysosome-related organelle (LRO) that contains surfactant, a complex mix of mainly lipids and specific surfactant proteins. The major function of surfactant in the lung is the reduction of surface tension and stabilization of alveoli during respiration. Its lack or deficiency may cause various forms of respiratory distress syndrome (RDS). Surfactant is also part of the innate immune system in the lung, defending the organism against air-borne pathogens. The limiting (organelle) membrane that encloses the LB contains various transporters that are in part responsible for translocating lipids and other organic material into the LB. On the other hand, this membrane contains ion transporters and channels that maintain a specific internal ion composition including the acidic pH of about 5. Furthermore, P2X receptors, ligand gated ion channels of the danger signal ATP, are expressed in the limiting LB membrane. They play a role in boosting surfactant secretion and fluid clearance. In this review, we discuss the functions of these transporting pathways of the LB, including possible roles in disease and as therapeutic targets, including viral infections such as SARS-CoV-2.

摘要

板层小体(LB)是肺泡 II 型(ATII)细胞的溶酶体相关细胞器(LRO),其中包含表面活性剂,这是一种主要由脂质和特定表面活性剂蛋白组成的复杂混合物。表面活性剂在肺部的主要功能是降低呼吸过程中的表面张力并稳定肺泡。其缺乏或不足可能导致各种形式的呼吸窘迫综合征(RDS)。表面活性剂也是肺部固有免疫系统的一部分,可保护机体免受空气传播病原体的侵害。包围 LB 的限制(细胞器)膜包含各种转运蛋白,部分负责将脂质和其他有机物质转运到 LB 中。另一方面,该膜包含离子转运蛋白和通道,可维持特定的内部离子组成,包括约 5 的酸性 pH 值。此外,P2X 受体,即危险信号 ATP 的配体门控离子通道,在限制的 LB 膜中表达。它们在促进表面活性剂分泌和液体清除方面发挥作用。在这篇综述中,我们讨论了 LB 的这些转运途径的功能,包括在疾病中的可能作用以及作为治疗靶点,包括 SARS-CoV-2 等病毒感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a2/8750383/8201c2debafc/cells-11-00045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a2/8750383/8201c2debafc/cells-11-00045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2a2/8750383/8201c2debafc/cells-11-00045-g001.jpg

相似文献

1
Channels and Transporters of the Pulmonary Lamellar Body in Health and Disease.肺部板层小体的通道和转运体:在健康和疾病中的作用。
Cells. 2021 Dec 24;11(1):45. doi: 10.3390/cells11010045.
2
Surfactant secretion in LRRK2 knock-out rats: changes in lamellar body morphology and rate of exocytosis.LRRK2 敲除大鼠的表面活性剂分泌:板层小体形态和胞吐率的变化。
PLoS One. 2014 Jan 21;9(1):e84926. doi: 10.1371/journal.pone.0084926. eCollection 2014.
3
Comparative proteomic analysis of lung lamellar bodies and lysosome-related organelles.肺板层小体和溶酶体相关细胞器的比较蛋白质组学分析。
PLoS One. 2011 Jan 26;6(1):e16482. doi: 10.1371/journal.pone.0016482.
4
Pulmonary surfactant protein SP-B promotes exocytosis of lamellar bodies in alveolar type II cells.肺表面活性物质蛋白 SP-B 促进肺泡 II 型细胞中板层小体的胞吐作用。
FASEB J. 2018 Aug;32(8):4600-4611. doi: 10.1096/fj.201701462RR. Epub 2018 Mar 15.
5
Fusion-activated cation entry (FACE) via P2X₄ couples surfactant secretion and alveolar fluid transport.P2X4 介导的融合激活阳离子内流(FACE)偶联表面活性剂分泌和肺泡液体转运。
FASEB J. 2013 Apr;27(4):1772-83. doi: 10.1096/fj.12-220533. Epub 2013 Jan 10.
6
Vacuolar ATPase regulates surfactant secretion in rat alveolar type II cells by modulating lamellar body calcium.液泡型 ATP 酶通过调节板层体钙来调节大鼠肺泡 II 型细胞表面活性剂的分泌。
PLoS One. 2010 Feb 16;5(2):e9228. doi: 10.1371/journal.pone.0009228.
7
GCN5L1 regulates pulmonary surfactant production by modulating lamellar body biogenesis and trafficking in mouse alveolar epithelial cells.GCN5L1 通过调节小鼠肺泡上皮细胞的板层小体发生和转运来调节肺表面活性剂的产生。
Cell Mol Biol Lett. 2023 Nov 7;28(1):90. doi: 10.1186/s11658-023-00506-0.
8
Distribution of surfactant protein A in rat lung.表面活性蛋白A在大鼠肺中的分布。
Am J Respir Cell Mol Biol. 1994 Oct;11(4):405-15. doi: 10.1165/ajrcmb.11.4.7917309.
9
Dynamics of surfactant release in alveolar type II cells.II型肺泡细胞表面活性剂释放的动力学
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1579-84. doi: 10.1073/pnas.95.4.1579.
10
Microfluidic shear stress-regulated surfactant secretion in alveolar epithelial type II cells in vitro.体外肺泡上皮细胞 II 型中微流体力调控表面活性剂分泌。
Am J Physiol Lung Cell Mol Physiol. 2014 Apr 1;306(7):L672-83. doi: 10.1152/ajplung.00106.2013. Epub 2014 Jan 31.

引用本文的文献

1
Acute Toxicity of Metal Oxide Nanoparticles-Role of Intracellular Localization In Vitro in Lung Epithelial Cells.金属氧化物纳米颗粒的急性毒性——体外细胞内定位在肺上皮细胞中的作用
Int J Mol Sci. 2025 Aug 30;26(17):8451. doi: 10.3390/ijms26178451.
2
Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunction.GM2神经节苷脂沉积症中的质膜重塑导致突触功能障碍。
PLoS Biol. 2025 Jul 3;23(7):e3003265. doi: 10.1371/journal.pbio.3003265. eCollection 2025 Jul.
3
Surfactant protein SP-B: one ring to rule the molecular and biophysical mechanisms of the pulmonary surfactant system.

本文引用的文献

1
Vesicle cholesterol controls exocytotic fusion pore.囊泡胆固醇控制胞吐融合孔。
Cell Calcium. 2022 Jan;101:102503. doi: 10.1016/j.ceca.2021.102503. Epub 2021 Nov 20.
2
Potential Therapeutic Applications of Pulmonary Surfactant Lipids in the Host Defence Against Respiratory Viral Infections.肺表面活性物质脂质在宿主防御呼吸道病毒感染中的潜在治疗应用。
Front Immunol. 2021 Sep 27;12:730022. doi: 10.3389/fimmu.2021.730022. eCollection 2021.
3
Mechanisms of SARS-CoV-2 entry into cells.SARS-CoV-2 进入细胞的机制。
表面活性蛋白SP-B:掌控肺表面活性物质系统分子与生物物理机制的关键一环。
Biophys Rev. 2025 Mar 18;17(2):653-666. doi: 10.1007/s12551-025-01285-y. eCollection 2025 Apr.
4
Alveolar epithelial paxillin in postnatal lung alveolar development.出生后肺肺泡发育中的肺泡上皮桩蛋白
Biol Open. 2025 Mar 15;14(3). doi: 10.1242/bio.061939. Epub 2025 Mar 20.
5
Acidic Enough for a Healthy Breath.酸性足够,呼吸更健康。
Am J Respir Cell Mol Biol. 2024 Oct;71(4):383-385. doi: 10.1165/rcmb.2024-0237ED.
6
Insights into Inhalation Drug Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters.吸入性药物处置的新视角:肺部药物代谢酶和转运体的作用。
Int J Mol Sci. 2024 Apr 25;25(9):4671. doi: 10.3390/ijms25094671.
7
Novel opportunities from bioimaging to understand the trafficking and maturation of intracellular pulmonary surfactant and its role in lung diseases.从生物成像中探索新机遇,以了解细胞内肺表面活性剂的运输和成熟过程及其在肺部疾病中的作用。
Front Immunol. 2023 Aug 10;14:1250350. doi: 10.3389/fimmu.2023.1250350. eCollection 2023.
8
Molecular Impact of Conventional and Electronic Cigarettes on Pulmonary Surfactant.常规和电子烟对肺表面活性剂的分子影响。
Int J Mol Sci. 2023 Jul 20;24(14):11702. doi: 10.3390/ijms241411702.
9
The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.嘌呤能信号在抗包括 SARS-CoV-2 在内的病毒方面的潜力。
Front Immunol. 2022 Jun 17;13:904419. doi: 10.3389/fimmu.2022.904419. eCollection 2022.
Nat Rev Mol Cell Biol. 2022 Jan;23(1):3-20. doi: 10.1038/s41580-021-00418-x. Epub 2021 Oct 5.
4
Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury.急性呼吸窘迫综合征和 COVID-19 肺损伤的病理生理学。
Crit Care Clin. 2021 Oct;37(4):749-776. doi: 10.1016/j.ccc.2021.05.003. Epub 2021 May 28.
5
Cell entry by SARS-CoV-2.新冠病毒 2 型的细胞进入。
Trends Biochem Sci. 2021 Oct;46(10):848-860. doi: 10.1016/j.tibs.2021.06.001. Epub 2021 Jun 7.
6
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines.伊维菌素用于预防和治疗 COVID-19 感染:系统评价、荟萃分析和试验序贯分析,为临床指南提供信息。
Am J Ther. 2021 Jun 21;28(4):e434-e460. doi: 10.1097/MJT.0000000000001402.
7
Cystic fibrosis.囊性纤维化。
Lancet. 2021 Jun 5;397(10290):2195-2211. doi: 10.1016/S0140-6736(20)32542-3.
8
Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.人表面活性剂蛋白 D 结合刺突蛋白并作为 SARS-CoV-2 假型病毒颗粒的进入抑制剂。
Front Immunol. 2021 May 14;12:641360. doi: 10.3389/fimmu.2021.641360. eCollection 2021.
9
AP-3-dependent targeting of flippase ATP8A1 to lamellar bodies suppresses activation of YAP in alveolar epithelial type 2 cells.AP-3 依赖性翻转酶 ATP8A1 向板层小体的靶向作用抑制肺泡上皮细胞 2 型中 YAP 的激活。
Proc Natl Acad Sci U S A. 2021 May 18;118(20). doi: 10.1073/pnas.2025208118.
10
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.COVID-19 组织图谱揭示了 SARS-CoV-2 的病理学和细胞靶标。
Nature. 2021 Jul;595(7865):107-113. doi: 10.1038/s41586-021-03570-8. Epub 2021 Apr 29.